You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
4 October 2024
26 July 2024
Merck KGaA: Strong 2nd Quarter, Guidance raised
24 June 2024
Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
23 May 2024
21 May 2024
16 May 2024
27 March 2024
Merck KGaA: Dr. Matthias Heinzel, buy
Merck KGaA: Peter Guenter, buy
25 January 2024
15 December 2023
13 December 2023
5 December 2023
Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide
27 November 2023
24 November 2023
22 November 2023
21 November 2023
15 November 2023
14 November 2023
13 November 2023
3 November 2023
25 October 2023
24 October 2023
23 October 2023
16 October 2023
27 September 2023
21 September 2023
18 September 2023
